We are live on ! Find out more
TECH icon

Bio-Techne

535 hedge funds and large institutions have $10.9B invested in Bio-Techne in 2022 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 213 increasing their positions, 180 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

231% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $4.86M

18% more repeat investments, than reductions

Existing positions increased: 213 | Existing positions reduced: 180

11.04% more ownership

Funds ownership: 379.13%390.17% (+11%)

3% less funds holding

Funds holding: 549535 (-14)

14% less first-time investments, than exits

New positions opened: 48 | Existing positions closed: 56

16% less capital invested

Capital invested by funds: $12.9B → $10.9B (-$2.02B)

50% less funds holding in top 10

Funds holding in top 10: 105 (-5)

Holders
535
Holders Change
-14
Holders Change %
-2.55%
% of All Funds
9.22%
Holding in Top 10
5
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-50%
% of All Funds
0.09%
New
48
Increased
213
Reduced
180
Closed
56
Calls
$16.1M
Puts
$4.86M
Net Calls
+$11.2M
Net Calls Change
+$2.59M

TECH Hedge Fund Activity: Q3 2022 in Review

535 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2022, worth a combined $10.9B — down 16% from $12.9B a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of TECH and 48 opened new positions — a net loss of 8 holders — while 180 trimmed existing stakes and 213 added.

The largest buyer was Janus Henderson Group, adding an estimated $86.1M. The largest seller was Massachusetts Financial Services, cutting an estimated $60.9M.

  • 535 institutional investors held Bio-Techne (TECH) as of Q3 2022, down from 549 in Q2 2022.
  • Funds reported $10.9B of Bio-Techne stock for Q3 2022, down 16% quarter-over-quarter.
  • 48 funds opened new Bio-Techne positions in Q3 2022 and 56 closed out, a net change of -8 holders.
  • The largest Bio-Techne buyer in Q3 2022 was Janus Henderson Group, an estimated $86.1M added.
  • The largest Bio-Techne seller in Q3 2022 was Massachusetts Financial Services, an estimated $60.9M sold.

Based on aggregated 13F filings for Q3 2022.